Sistemic Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Sistemic General Information

Description

Developer of microRNA analysis technology intended to offer products for the bioprocessing, cell therapy and drug discovery and development markets. The company focuses on the analysis of the information content of microRNA and other non-coding RNAs for applications in the development of cell therapies and drug repositioning, enabling healthcare professionals to easily develop cell therapies and drug repositioning without any hassle.

Contact Information

Formerly Known As
MM&S (5330)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Campbell House, Central Business Park
  • Greenside Road
  • Glasgow ML1 5FL
  • Scotland, United Kingdom
+44 0141
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Corporate Office
  • Campbell House, Central Business Park
  • Greenside Road
  • Glasgow ML1 5FL
  • Scotland, United Kingdom
+44 0141

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sistemic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 01-Dec-2025 Completed Generating Revenue
7. Later Stage VC 10-Apr-2020 Completed Generating Revenue
6. Later Stage VC 11-Jan-2018 Completed Generating Revenue
5. Grant 22-Jun-2017 Completed Generating Revenue
4. Later Stage VC 26-Dec-2015 Completed Generating Revenue
3. Later Stage VC 22-Oct-2014 Completed Generating Revenue
2. Later Stage VC 18-Nov-2013 $327K $1.32M Completed Generating Revenue
1. Early Stage VC (Series A) 17-Mar-2010 $990K $990K Completed Generating Revenue
To view Sistemic’s complete valuation and funding history, request access »

Sistemic Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 362,242 $0.000122 $0.91 $0.91 1x $0.91 20.45%
Ordinary 106,600 $0.000122 $0.36 $0.36 1x $0.36 6.02%
To view Sistemic’s complete cap table history, request access »

Sistemic Patents

Sistemic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260275416-A1 Cell contamination assay Pending 20-Jul-2020
GB-201809336-D0 Cell contamination assay Inactive 06-Jun-2018
GB-201809337-D0 Cell contamination assay Inactive 06-Jun-2018
GB-201809338-D0 Cell contamination assay Inactive 06-Jun-2018
GB-201809238-D0 Call contamination assay Inactive 05-Jun-2018
To view Sistemic’s complete patent history, request access »

Sistemic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sistemic Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
ChimaeraBio Corporation Minority
To view Sistemic’s complete investors history, request access »

Sistemic FAQs

  • When was Sistemic founded?

    Sistemic was founded in 2007.

  • Where is Sistemic headquartered?

    Sistemic is headquartered in Glasgow, United Kingdom.

  • What is the size of Sistemic?

    Sistemic has 8 total employees.

  • What industry is Sistemic in?

    Sistemic’s primary industry is Drug Discovery.

  • Is Sistemic a private or public company?

    Sistemic is a Private company.

  • What is Sistemic’s current revenue?

    The current revenue for Sistemic is .

  • How much funding has Sistemic raised over time?

    Sistemic has raised $3.93M.

  • Who are Sistemic’s investors?

    ChimaeraBio has invested in Sistemic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process